Interaksi Sitalopram dan Vilazodon

Sitalopram dan Vilazodon: kedua label peresepan menandai kombinasi ini dengan bahasa yang paling tegas, seperti kontraindikasi, peringatan kotak hitam, atau instruksi untuk menghindarinya.

Mayor

Jangan dikombinasikan tanpa arahan dokter yang meresepkan. Bahasa label di bawah ini adalah yang paling tegas yang digunakan FDA.

Apa kata label FDA

Dari label Sitalopram (citalopram) · berlaku sejak 2025-10-07

Mayor

Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents, but also when taken alone.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Mayor

If concomitant use of Citalopram Capsules with other serotonergic drugs is clinically warranted, inform patients of the increased risk for serotonin syndrome and monitor for symptoms.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, meperidine, methadone, tryptophan, buspirone, amphetamines, and St.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Minor

Activation of Mania or Hypomania In patients with bipolar disorder, treating a depressive episode with Citalopram Capsules or another antidepressant may precipitate a mixed/manic episode.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Minor

Other Serotonergic Drugs Clinical Impact: Concomitant use of Citalopram Capsules with other serotonergic drugs (including other SSRIs, SNRIs, triptans, tricyclic antidepressants, opioids, lithium, buspirone, amphetamines, tryptophan, and St.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed

Dari label Vilazodon (VIIBRYD) · berlaku sejak 2023-10-01

Mayor

Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents, but also when taken alone.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Mayor

If concomitant use of VIIBRYD with other serotonergic drugs is clinically warranted, inform patients of the increased risk for serotonin syndrome and monitor for symptoms.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, meperidine, methadone, lithium, tramadol, tryptophan, buspirone, amphetamines, and St.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Minor

Activation of Mania or Hypomania In patients with bipolar disorder, treating a depressive episode with VIIBRYD or another antidepressant may precipitate a mixed/manic episode.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Minor

Other Serotonergic Drugs Concomitant use of VIIBRYD with other serotonergic drugs (including other SSRIs, SNRIs, triptans, tricyclic antidepressants, opioids, lithium, buspirone, amphetamines, tryptophan, and St.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed

Menggunakan lebih dari dua obat ini? Interaksi saling bertumpuk. Periksa seluruh daftar Anda sekaligus; daftar itu tetap berada di peramban Anda.

Buka di pemeriksa

Bukan nasihat medis. Interaction Checker mengutip teks label FDA dan lembar fakta NIH. Penting atau tidaknya suatu interaksi bagi Anda bergantung pada dosis, waktu penggunaan, fungsi ginjal dan hati, serta kondisi lain. Pastikan dengan apoteker atau dokter yang meresepkan.